Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.

Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.

Public comments invited on the draft amendments to the New Drugs and Clinical Trials Rules by 5th Feb, 2022; proposes to introduce deemed approval w.r.t. registration of Ethics Committee, conducting all clinical trials etc.

by Lexplosion | Feb 1, 2022 | Central, Drug, OPS

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

DGCI classifies medical device pertaining to Paediatrics & Neonatology, Obstetrical & Gynaecological and Urology under the provisions of Medical Devices Rules, 2017

by Lexplosion Solution | Aug 27, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Manufacturers and importers of knee implants directed to furnish pricing data on orthopedic knee implants (for knee replacement system) by 12th August, 2021 in format prescribed by the pricing authority

Manufacturers and importers of knee implants directed to furnish pricing data on orthopedic knee implants (for knee replacement system) by 12th August, 2021 in format prescribed by the pricing authority

by Lexplosion | Aug 9, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021

CDSCO proposes the Draft New Drugs and Clinical Trials (Amendment) Rules, 2021; invites objections/suggestions by 14th September, 2021

by Lexplosion | Aug 5, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

Department of Commerce restricts the export of Remdesivir Injection & Remdesivir Active Pharmaceutical Ingredients (API) ; no separate export authorization will be required

by Lexplosion Solution | Jun 17, 2021 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

« Older Entries

Next Entries »